Shire should be bought after court decision, says Buckingham After an appeals court ordered a district court to reconsider the patent on Shire's Lialda, Buckingham does not think the order means that a generic version of Lialda will be launched in the near-term. The firm thinks that the district court could take years to decide the case. It keeps a $200 price target on Shire.
News For SHPG From The Last 14 Days
Check below for free stories on SHPG the last two weeks.